SCHEMBL6353448

SCHEMBL6353448

Cc1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)O)cc1I

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 10/20 0.64
AKR1C4 P17516 1/20 0.62
AKR1C3 P42330 1/20 0.62
AKR1C2 P52895 1/20 0.62
AKR1C1 Q04828 1/20 0.62
CA2 P00918 3/20 0.60
CA9 Q16790 3/20 0.60
CA12 O43570 2/20 0.60
CA1 P00915 2/20 0.60
CA7 P43166 1/20 0.60
MEN1 O00255 1/20 0.60
LMNA P02545 1/20 0.60
MAPT P10636 1/20 0.60
RAB9A P51151 1/20 0.60
KMT2A Q03164 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
KDM4E B2RXH2 1/20 0.57
HSD17B10 Q99714 1/20 0.57
KCNK2 O95069 1/20 0.56
KCNK10 P57789 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349535 0.82 SERPINE1 (0.74) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL19554134 0.81 SERPINE1 (0.68) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL28713882 0.79 HDAC8 (0.62) MEN1LMNAMAPTRAB9AKMT2A
SCHEMBL6358123 0.79 SERPINE1 (0.89) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6351321 0.79 SERPINE1 (0.89) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL420142 0.78 SERPINE1 (1.00) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6352581 0.78 AKR1C4 (0.78) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL19554199 0.78 SERPINE1 (0.57) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL11231268 0.78 CHEK1 (0.70) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL7089912 0.77 KCNMA1 (0.68) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SERPINE1 1929/4885AKR1C4 3065/4885AKR1C3 3288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.